
CAS 1351611-14-7
:Sortieren nach
Reinheit (%)
0
100
|
0
|
50
|
90
|
95
|
100
6 Produkte.
Apixaban Related Compound D (N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide)
CAS:Lactams, nesoiFormel:C26H25N5O5Farbe und Form:White Off-White PowderMolekulargewicht:487.18557N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
CAS:N-Formyl-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamideReinheit:97%Molekulargewicht:487.52g/molApixaban USP Related Compound D
CAS:Formel:C26H25N5O5Farbe und Form:White To Off-White SolidMolekulargewicht:487.52N-Formyl Apixaban
CAS:Kontrolliertes ProduktApplications N-Formyl Apixaban is derived from Apixaban (A726700) which is a potent, direct, selective, and orally active inhibitor of coagulation factor Xa. It is a potential new oral coagulant that may be useful prevention of venous thromboembolism in total hip, knee replacement orthopedic surgery and stroke in treatment of patient with venous thromboembolic disorder or with atrial fibrillation.
References Luettgen, J.M. et al.: J. Enz. Inhib. Med. Chem., 26, 514 (2011); Glanis, T. et al.: J. Thromb. Thrombol., 31, 310 (2011); barrett, Y.C. et al.: Thromb. Haemos., 105, 181 (2011);Formel:C26H25N5O5Farbe und Form:NeatMolekulargewicht:487.51N-Formyl apixaban
CAS:Please enquire for more information about N-Formyl apixaban including the price, delivery time and more detailed product information at the technical inquiry form on this pageFormel:C26H25N5O5Reinheit:Min. 95%Molekulargewicht:487.5 g/mol






